211 related articles for article (PubMed ID: 38010649)
1. The potential of PCNA inhibition as a therapeutic strategy in cervical cancer.
Wendel SO; Snow JA; Gu L; Banerjee NS; Malkas L; Wallace NA
J Med Virol; 2023 Nov; 95(11):e29244. PubMed ID: 38010649
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of proliferating cell nuclear antigen (PCNA) is closely associated with high-risk human papillomavirus (HPV) and progression of cervical intraepithelial neoplasia (CIN), but does not predict disease outcome in cervical cancer.
Branca M; Ciotti M; Giorgi C; Santini D; Di Bonito L; Costa S; Benedetto A; Bonifacio D; Di Bonito P; Paba P; Accardi L; Syrjänen S; Favalli C; Syrjänen K;
Eur J Obstet Gynecol Reprod Biol; 2007 Feb; 130(2):223-31. PubMed ID: 17098349
[TBL] [Abstract][Full Text] [Related]
3. [Comparative study of HPV infection and proliferating cell nuclear antigen of uterine cervix].
Murakami T; Nagai N; Ota S; Ohama K
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Sep; 45(9):967-72. PubMed ID: 8103785
[TBL] [Abstract][Full Text] [Related]
4. Expression of the proliferating cell nuclear antigen in cervical neoplasia.
Raju GC
Int J Gynecol Pathol; 1994 Oct; 13(4):337-41. PubMed ID: 7814195
[TBL] [Abstract][Full Text] [Related]
5. Relevance of the rates of PCNA, Ki-67 and p53 expression according to the epithelial compartment in cervical lesions.
Maeda MY; Simões M; Wakamatsu A; Longatto Filho AL; Oyafuso M; de Mello ES; Otta MM; Alves VA
Pathologica; 2001 Jun; 93(3):189-95. PubMed ID: 11433611
[TBL] [Abstract][Full Text] [Related]
6. Decrease in tumor volume and histologic response to intraarterial neoadjuvant chemotherapy in patients with cervical and endometrial adenocarcinoma.
Fujiwaki R; Takahashi K; Kitao M
Gynecol Oncol; 1997 May; 65(2):258-64. PubMed ID: 9159335
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA CCHE1 promotes cervical cancer cell proliferation via upregulating PCNA.
Yang M; Zhai X; Xia B; Wang Y; Lou G
Tumour Biol; 2015 Sep; 36(10):7615-22. PubMed ID: 25921283
[TBL] [Abstract][Full Text] [Related]
8. Predictive significance of the alterations of p16INK4A, p14ARF, p53, and proliferating cell nuclear antigen expression in the progression of cervical cancer.
Wang JL; Zheng BY; Li XD; Angström T; Lindström MS; Wallin KL
Clin Cancer Res; 2004 Apr; 10(7):2407-14. PubMed ID: 15073118
[TBL] [Abstract][Full Text] [Related]
9. The correlation between HPV infection and cell proliferative activity in uterine cervical adenocarcinoma.
Shikano K; Sasano H; Ito K; Ozawa N; Tase T; Sato S; Yajima A
Tohoku J Exp Med; 1993 Apr; 169(4):279-88. PubMed ID: 7902617
[TBL] [Abstract][Full Text] [Related]
10. [Expression of PCNA antigen in cellular proliferative activity of cervical carcinoma].
Lenczewski A; Terlikowski S; Sulkowska M; Famulski W; Dobrzycka B; Sulkowski S; Musiatowicz B; Kulikowski M
Ginekol Pol; 2000 Sep; 71(9):1164-8. PubMed ID: 11082996
[TBL] [Abstract][Full Text] [Related]
11. p53, retinoblastoma gene product, and cyclin protein expression in human papillomavirus virus DNA-positive cervical intraepithelial neoplasia and invasive cancer.
Amortegui AJ; Meyer MP; Elborne VL; Amin RM
Mod Pathol; 1995 Dec; 8(9):907-12. PubMed ID: 8751330
[TBL] [Abstract][Full Text] [Related]
12. Expression of the cervical carcinoma expressed PCNA regulatory (CCEPR) long noncoding RNA is driven by the human papillomavirus E6 protein and modulates cell proliferation independent of PCNA.
Sharma S; Munger K
Virology; 2018 May; 518():8-13. PubMed ID: 29427865
[TBL] [Abstract][Full Text] [Related]
13. Proliferating cell nuclear antigen immunoreactivity in cervical intraepithelial neoplasia and benign cervical epithelium.
Shurbaji MS; Brooks SK; Thurmond TS
Am J Clin Pathol; 1993 Jul; 100(1):22-6. PubMed ID: 8102221
[TBL] [Abstract][Full Text] [Related]
14. [Histopathological and immunohistochemical analysis (proliferating cel nuclear antigen) of patients with invasive cervical carcinoma before and after radiotherapy and surgery].
Rosal MA; Gonçalves WJ; Alves MT; Baracat EC; de Lima GR
Rev Assoc Med Bras (1992); 2002; 48(1):32-5. PubMed ID: 12185633
[TBL] [Abstract][Full Text] [Related]
15. [Highly expressed CHAF1A and PCNA are positively associated with malignancy of cervical squamous cell carcinoma].
Luo Y; Wang Q; Tian P; Jia Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Dec; 33(12):1696-1701. PubMed ID: 29382432
[TBL] [Abstract][Full Text] [Related]
16. [Human papillomavirus type 16 E6 oncogene and expression of P53, RB and PCNA in human cervical carcinoma].
Bian J; Yu X; Dong J; Zhao W; Zhou Y; Luan Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):271-3. PubMed ID: 15617346
[TBL] [Abstract][Full Text] [Related]
17. The relationship between proliferating cell nuclear antigen (PCNA), nuclear DNA content and mutant p53 during genesis of cervical carcinoma.
Steinbeck RG; Heselmeyer KM; Moberger HB; Auer GU
Acta Oncol; 1995; 34(2):171-6. PubMed ID: 7718254
[TBL] [Abstract][Full Text] [Related]
18. The association of vascular proliferation with HPV status and epithelial PCNA positivity in cervical intraepithelial lesions.
Soini Y; Pöllänen R; Kemppainen S; Pääkkö P; Lehto VP
APMIS; 1996 Mar; 104(3):183-90. PubMed ID: 8611192
[TBL] [Abstract][Full Text] [Related]
19. Proliferation profile of benign and premalignant cervical epithelium as established by PCNA staining pattern.
Boon ME; Luzzatto R; Beck S; Bosch MM; Hermans J; Rietveld WJ
Pathol Res Pract; 1994 Apr; 190(4):372-7. PubMed ID: 7915836
[TBL] [Abstract][Full Text] [Related]
20. Tumor response to neoadjuvant chemotherapy correlates with the expression of P-glycoprotein and PCNA but not GST-pi in the tumor cells of cervical carcinoma.
Konishi I; Nanbu K; Mandai M; Tsuruta Y; Kataoka N; Nagata Y; Mori T
Gynecol Oncol; 1998 Sep; 70(3):365-71. PubMed ID: 9790789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
